Results
The cases are 221 basal and 294 by progression after first line TKIs
treatment. The cases with mutation, as expected, have an OR 4,15
compared to the basal to have a tumor progression ( 95% IC: 2,7
- 6,3) regardless of sex and age. The mutations detected were 131 from
different types of lung carcinomas.